Peidong Liu

951 total citations
37 papers, 685 citations indexed

About

Peidong Liu is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Peidong Liu has authored 37 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Genetics, 10 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in Peidong Liu's work include Glioma Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Cells and Metastasis (4 papers). Peidong Liu is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), MicroRNA in disease regulation (6 papers) and Cancer Cells and Metastasis (4 papers). Peidong Liu collaborates with scholars based in China, United States and Germany. Peidong Liu's co-authors include Yi Li, Luqing Tong, Xuejun Yang, Haiwen Ma, Shengping Yu, Yang Xie, Hai Long, Jiabo Li, Zhennan Tao and Feng Yuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Peidong Liu

35 papers receiving 675 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peidong Liu China 15 275 179 166 135 112 37 685
Daofeng Tian China 18 459 1.7× 113 0.6× 232 1.4× 125 0.9× 135 1.2× 47 862
Roberta Angioni Italy 14 270 1.0× 227 1.3× 91 0.5× 162 1.2× 98 0.9× 19 703
Carolina Batista Ariza Brazil 12 207 0.8× 126 0.7× 83 0.5× 167 1.2× 98 0.9× 23 536
Meiqing Lou China 16 352 1.3× 82 0.5× 142 0.9× 114 0.8× 94 0.8× 40 705
Xiao–Tang Kong United States 12 339 1.2× 109 0.6× 80 0.5× 190 1.4× 180 1.6× 51 679
Deanna M. Patmore United States 7 627 2.3× 143 0.8× 100 0.6× 85 0.6× 157 1.4× 8 863
Hisayuki Yao Japan 15 377 1.4× 246 1.4× 81 0.5× 210 1.6× 175 1.6× 34 896
Takenobu Nakagawa Japan 10 184 0.7× 299 1.7× 62 0.4× 179 1.3× 98 0.9× 20 648
Ae Kyung Park South Korea 15 334 1.2× 52 0.3× 211 1.3× 101 0.7× 119 1.1× 28 647
Jingya Miao United States 13 180 0.7× 195 1.1× 66 0.4× 146 1.1× 58 0.5× 37 566

Countries citing papers authored by Peidong Liu

Since Specialization
Citations

This map shows the geographic impact of Peidong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peidong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peidong Liu more than expected).

Fields of papers citing papers by Peidong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peidong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peidong Liu. The network helps show where Peidong Liu may publish in the future.

Co-authorship network of co-authors of Peidong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Peidong Liu. A scholar is included among the top collaborators of Peidong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peidong Liu. Peidong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hui, et al.. (2024). Re-establishing immune tolerance in multiple sclerosis: focusing on novel mechanisms of mesenchymal stem cell regulation of Th17/Treg balance. Journal of Translational Medicine. 22(1). 663–663. 14 indexed citations
2.
Liu, Peidong, Xinwei Li, Jun‐Cheng Su, et al.. (2024). Rutaecarpine analogues with potent anti-inflammation to alleviate acute ulcerative colitis via regulating TLR4/MAPK/NF-κB pathway. Results in Chemistry. 7. 101330–101330. 5 indexed citations
3.
Zhang, Chengming, et al.. (2023). The silencing of NREP aggravates OA cartilage damage through the TGF-β1/Smad2/3 pathway in chondrocytes. Journal of Orthopaedic Translation. 44. 26–34. 2 indexed citations
5.
Liu, Ju, Xiaoyan Yang, Zhihua Wei, et al.. (2022). Single-Cell Transcriptome Profiling Unravels Distinct Peripheral Blood Immune Cell Signatures of RRMS and MOG Antibody-Associated Disease. Frontiers in Neurology. 12. 807646–807646. 6 indexed citations
6.
Yang, Xiaoyan, Jing Peng, Xiaoxi Huang, et al.. (2021). Association of Circulating Follicular Helper T Cells and Serum CXCL13 With Neuromyelitis Optica Spectrum Disorders. Frontiers in Immunology. 12. 677190–677190. 14 indexed citations
7.
Tong, Luqing, Jiabo Li, Xuya Wang, et al.. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 10(13). 5943–5956. 112 indexed citations
8.
Liu, Peidong, et al.. (2020). Diagnostic value of orbicularis oculi muscle electromyography in functional epiphora. World Journal of Clinical Cases. 8(14). 3000–3005. 2 indexed citations
9.
Li, Jiabo, Luqing Tong, Yi Li, et al.. (2019). ACT001 inhibits the neurosphere formation and stemness maintenance of U87-MG glioma stem cells through STAT3 signaling pathway. Zhonghua shenjing waike zazhi. 35(11). 1160–1166. 1 indexed citations
10.
Li, Yi, Xingchen Zhou, Tao Li, et al.. (2019). Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4. Journal of Experimental & Clinical Cancer Research. 38(1). 339–339. 105 indexed citations
11.
Yuan, Feng, Yi Li, Hai Long, et al.. (2019). Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses. Disease Markers. 2019. 1–13. 13 indexed citations
12.
Tong, Luqing, Jiabo Li, John Choi, et al.. (2019). CLEC5A expressed on myeloid cells as a M2 biomarker relates to immunosuppression and decreased survival in patients with glioma. Cancer Gene Therapy. 27(9). 669–679. 20 indexed citations
13.
Yuan, Feng, Haolang Ming, Yingshuai Wang, et al.. (2019). Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples. Journal of Cellular Physiology. 235(5). 4326–4334. 39 indexed citations
14.
Zhang, Hui, Peidong Liu, Min Chen, et al.. (2018). IL-23 and IL-27 Levels in Serum are Associated with the Process and the Recovery of Guillain-Barré Syndrome. Scientific Reports. 8(1). 2824–2824. 16 indexed citations
15.
Tong, Luqing, Yi Li, Peidong Liu, et al.. (2018). Tumour cell dormancy as a contributor to the reduced survival of GBM patients who received standard therapy. Oncology Reports. 40(1). 463–471. 15 indexed citations
16.
Liu, Hongbo, et al.. (2016). Polymorphisms in exon 2 of CD1 genes are associated with susceptibility to Guillain–Barré syndrome. Journal of the Neurological Sciences. 369. 39–42. 13 indexed citations
17.
Gong, Zhe, Jing Zhang, Peidong Liu, et al.. (2015). Elevated Serum MicroRNA Let-7c in Moyamoya Disease. Journal of Stroke and Cerebrovascular Diseases. 24(8). 1709–1714. 19 indexed citations
18.
Gong, Zhe, Jing Zhang, Wenjuan Guan, et al.. (2015). Initial research on the relationship between let-7 family members in the serum and massive cerebral infarction. Journal of the Neurological Sciences. 361. 150–157. 21 indexed citations
19.
Zhang, Jing, Zhe Gong, Peidong Liu, et al.. (2015). The Expression and Significance of the Plasma Let-7 Family in Anti-N-methyl-d-aspartate Receptor Encephalitis. Journal of Molecular Neuroscience. 56(3). 531–539. 22 indexed citations
20.
Li, Weimin, Yue Li, Jiyi Zhao, et al.. (2007). Safety and feasibility of emergent percutaneous coronary intervention with the transradial access in patients with acute myocardial infarction. Chinese Medical Journal. 120(7). 598–600. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026